Pantoprazole is indicated for the treatment and prevention of acid-related disorders in hospital settings, including gastrointestinal bleeding, stress ulcer prophylaxis in critically ill patients, and severe gastroesophageal reflux disease when oral therapy is not feasible. Its key advantage is rapid and sustained suppression of gastric acid secretion via proton pump inhibition, providing effective control of gastric pH. In ICU patients, maintaining higher gastric pH is crucial to reduce the risk of bleeding and protect the gastrointestinal mucosa under stress conditions such as mechanical ventilation, sepsis, or major surgery. Intravenous administration ensures reliable effect in patients who are unable to take oral medications. Pantoprazole is widely used due to its strong safety profile, minimal drug interactions, and predictable efficacy, making it a standard of care in acute and critical care environments.